Why the study?
Cardiovascular disease is the leading cause of death in China, prompting the need to standardize risk factor management and promote healthy lifestyles through tailored primary prevention recommendations.
Population
Chinese population for primary prevention of cardiovascular diseases
Design
Clinical practice guideline
Loading...
Guides primary CVD prevention in China; extends international guidelines with population-specific risk assessment and management.
This guideline provides comprehensive, evidence-based recommendations for the primary prevention of cardiovascular diseases tailored to the Chinese population.
A 2020 study studied this question. The Chinese guideline on cardiovascular disease primary prevention outlines recommendations for lifestyle interventions, risk assessment, and managing lipids, blood pressure, diabetes, and aspirin use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: